INTERNATIONAL PATENT: ENLITISA (SHANGHAI) PHARMACEUTICAL CO., LTD. FILES APPLICATION FOR "NEW USE OF PEPTIDES DERIVED FROM VASOACTIVE INTESTINAL PEPTIDE"

GENEVA, Sept. 28 -- ENLITISA (SHANGHAI) PHARMACEUTICAL CO., LTD. (Room 201, 202, 203, Building A, Block 1, No. 800, Qingdai RoadPudong New Area, Shanghai 201318) filed a patent application (PCT/CN2025/083665) for "NEW USE OF PEPTIDES DERIVED FROM VASOACTIVE INTESTINAL PEPTIDE" on Mar 20, 2025. With publication no. WO/2025/195444, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KANG, Ruijuan (Room 201, 202, 203, Building A, Block 1, No. 800, Qingdai RoadPudong New Area, Shanghai 201318), GU, Ming (Room 201, 202, 203, Build...